DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zantac (Ranitidine) - Adverse Event Reports - Life Threatening Events - Oxygen Saturation Decreased

 



Index of reports > Cases resulting in life threatening events (25) > Cases with Oxygen Saturation Decreased (5)

Below is the selection of adverse event reports related to Zantac (Ranitidine) that includes cases resulting in life threatening events where reactions include oxygen saturation decreased.

Adverse event in 35 year old female receiving Zantac (Ranitidine)

Reported by a consumer/non-health professional from United Kingdom on 2007-04-23

Patient: 35 year old female

Adverse reactions / side effects: Hypersensitivity, Mydriasis, Pharyngeal Oedema, Miosis, Aphasia, Vision Blurred, Oxygen Saturation Decreased, Laryngospasm

Adverse event resulted in: life threatening event

Suspect drug(s):
Zantac (Ranitidine)

Other drugs received by patient: Cefuroxime; Cyclizine; Metronidazole; Ondansetron; Paracetamol; Tinzaparin; Paracetamol



Adverse event in 77 year old female receiving Zantac (Ranitidine)

Reported by a physician from Japan on 2007-04-02

Patient: 77 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Urinary Incontinence, Hypotension, Cyanosis, Palpitations, Depressed Level of Consciousness, Cold Sweat, Shock, Oxygen Saturation Decreased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Decadron
    Dosage: 8ml per day
    Indication: Premedication
    Start date: 2007-02-22
    End date: 2007-02-22

Restamin
    Dosage: 5tab per day
    Administration route: Oral
    Indication: Premedication
    Start date: 2007-02-22
    End date: 2007-02-27

Zantac
    Dosage: 8ml per day
    Indication: Premedication
    Start date: 2007-02-22
    End date: 2007-02-22

Other drugs received by patient: Solita-T No.3



Adverse event in 35 year old female receiving Zantac (Ranitidine)

Reported by a pharmacist from United Kingdom on 2007-03-20

Patient: 35 year old female

Adverse reactions / side effects: Mydriasis, Hypersensitivity, Aphasia, Pharyngeal Oedema, Miosis, Vision Blurred, Pharmaceutical Product Complaint, Laryngospasm, Oxygen Saturation Decreased

Adverse event resulted in: life threatening event

Suspect drug(s):
Zantac (Ranitidine)



Adverse event in 35 year old female receiving Zantac (Ranitidine)

Reported by a pharmacist from United Kingdom on 2007-02-09

Patient: 35 year old female

Adverse reactions / side effects: Mydriasis, Hypersensitivity, Aphasia, Pharyngeal Oedema, Miosis, Vision Blurred, Pharmaceutical Product Complaint, Laryngospasm, Oxygen Saturation Decreased

Adverse event resulted in: life threatening event

Suspect drug(s):
Zantac (Ranitidine)



Adverse event in 35 year old female receiving Zantac (Ranitidine)

Reported by a pharmacist from United Kingdom on 2007-02-08

Patient: 35 year old female

Adverse reactions / side effects: Mydriasis, Hypersensitivity, Aphasia, Pharyngeal Oedema, Miosis, Vision Blurred, Pharmaceutical Product Complaint, Laryngospasm, Oxygen Saturation Decreased

Adverse event resulted in: life threatening event

Suspect drug(s):
Zantac (Ranitidine)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009